ERH is a prognostic biomarker associated with immune cell infiltration in lung cancer

Mingfang Huang,Xiuming Huang,Liang Li
DOI: https://doi.org/10.1080/1354750x.2024.2418579
2024-10-31
Biomarkers
Abstract:Introduction The enhancer of rudimentary homolog (ERH) is significant in cancers, but its role in lung cancer is understudied.
biotechnology & applied microbiology,toxicology
What problem does this paper attempt to address?